These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


388 related items for PubMed ID: 11128665

  • 21. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
    Baldwin D, Bridgman K, Buis C.
    J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
    Pezzella G, Moslinger-Gehmayr R, Contu A.
    Breast Cancer Res Treat; 2001 Nov; 70(1):1-10. PubMed ID: 11766999
    [Abstract] [Full Text] [Related]

  • 27. Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison.
    Skrumsager BK, Jeppesen K.
    Pharmacopsychiatry; 1986 Sep; 19(5):368-77. PubMed ID: 3774871
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO, Gattaz WF, Rigonatti SP, Rosa MA, Fregni F, Rosa MO, Mansur C, Myczkowski ML, Moreno RA, Marcolin MA.
    Biol Psychiatry; 2005 Jan 15; 57(2):162-6. PubMed ID: 15652875
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline.
    Hutchinson DR, Tong S, Moon CA, Vince M, Clarke A.
    Int Clin Psychopharmacol; 1992 Jun 15; 6 Suppl 4():43-51. PubMed ID: 1431010
    [Abstract] [Full Text] [Related]

  • 35. The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.
    Nemeroff CB.
    Pharmacotherapy; 1994 Jun 15; 14(2):127-38. PubMed ID: 8197030
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
    Pilhatsch M, Wolf R, Winter C, Lewitzka U, Bauer M.
    J Affect Disord; 2010 Nov 15; 126(3):453-7. PubMed ID: 20547424
    [Abstract] [Full Text] [Related]

  • 39. Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial.
    Sacchetti E, Cassano GB, Penati G, Pavan L, Nardini M, Casacchia M, Pancheri P, Muscettola G, Faravelli C, Aguglia E, Nivoli G, Ravizza L, Castrogiovanni P.
    Int J Psychiatry Clin Pract; 2002 Nov 15; 6(1):23-9. PubMed ID: 24931886
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.